JPMorgan Chase & Co. Cuts Alignment Healthcare (NASDAQ:ALHC) Price Target to $10.00

Key Points

• JPMorgan cut Alignment Healthcare’s price target from $22 to $10 while maintaining an “overweight” rating, implying about 32% upside from the stock’s $7.55 closing price.
• ALHC shares fell 13.3% to $7.55 on heavy trading volume, well below their 12-month high of $25.12. Despite the selloff, analysts maintain a “Moderate Buy” consensus with an average target of $19.18.
• Recent analyst sentiment has been mixed, with William Blair downgrading the stock and several firms lowering targets, while Alignment reported better-than-expected quarterly earnings and 31.6% year-over-year revenue growth.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) had its target price reduced by research analysts at JPMorgan Chase & Co. from $22.00 to $10.00 in a research report issued on Friday, Benzinga reports. The firm currently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s price objective indicates a potential upside of 32.45% from the stock's current price.

A number of other research analysts have also weighed in on the company. TD Cowen reissued a "buy" rating on shares of Alignment Healthcare in a research note on Wednesday, September 16th. William Blair downgraded Alignment Healthcare from an "outperform" rating to a "market perform" rating in a research report on Friday. Raymond James Financial cut shares of Alignment Healthcare from a "strong-buy" rating to an "outperform" rating and decreased their target price for the stock from $22.00 to $19.00 in a research report on Monday, August 3rd. Barclays lowered their target price on shares of Alignment Healthcare from $16.00 to $10.00 and set an "equal weight" rating for the company in a report on Tuesday. Finally, Scotiabank set a $9.00 price target on shares of Alignment Healthcare in a research report on Friday. Seven investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Alignment Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $19.18.

Alignment Healthcare Trading Down 13.3%

NASDAQ:ALHC traded down $1.16 on Friday, reaching $7.55. The stock had a trading volume of 21,301,121 shares, compared to its average volume of 5,567,272. Alignment Healthcare has a 12-month low of $6.01 and a 12-month high of $25.12. The company has a market cap of $1.57 billion, a price-to-earnings ratio of 40.03 and a beta of 1.14. The firm's fifty day moving average is $11.64 and its two-hundred day moving average is $16.70. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping analysts' consensus estimates of $0.13 by $0.04. The business had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.31 billion. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The company's quarterly revenue was up 31.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.07 earnings per share. Equities analysts expect that Alignment Healthcare will post 0.17 EPS for the current fiscal year.

Insider Buying and Selling

In other Alignment Healthcare news, President Dawn Maroney sold 122,707 shares of the stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $12.68, for a total value of $1,555,924.76. Following the completion of the sale, the president owned 794,606 shares of the company's stock, valued at $10,075,604.08. This trade represents a 13.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Hyong Kim sold 32,479 shares of Alignment Healthcare stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $8.30, for a total transaction of $269,575.70. Following the sale, the insider owned 299,271 shares in the company, valued at $2,483,949.30. This represents a 9.79% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 1,061,967 shares of company stock valued at $13,642,490. 5.20% of the stock is owned by company insiders.

Institutional Investors Weigh In On Alignment Healthcare

A number of large investors have recently added to or reduced their stakes in ALHC. WINTON GROUP Ltd acquired a new position in Alignment Healthcare in the 2nd quarter worth $1,164,000. Arizona State Retirement System grew its stake in shares of Alignment Healthcare by 15.8% during the second quarter. Arizona State Retirement System now owns 53,553 shares of the company's stock valued at $1,275,000 after acquiring an additional 7,318 shares in the last quarter. Nykredit A S purchased a new stake in shares of Alignment Healthcare during the second quarter worth about $36,000. Corient Private Wealth LP increased its position in shares of Alignment Healthcare by 128.2% during the second quarter. Corient Private Wealth LP now owns 136,505 shares of the company's stock worth $3,250,000 after acquiring an additional 76,677 shares during the last quarter. Finally, HighTower Advisors LLC acquired a new position in shares of Alignment Healthcare in the second quarter worth about $755,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare News Summary

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Six of Alignment Healthcare’s seven eligible Medicare Advantage contracts earned 4 Stars or higher, including three plans that received 4.5 Stars. The contracts cover markets in Arizona, California, Nevada, North Carolina and Texas, supporting the company’s quality-care positioning. Alignment Healthcare 2027 Star Ratings
• Positive Sentiment: KeyCorp lowered its price target from $28 to $12 but maintained an “overweight” rating, implying substantial potential upside from recent trading levels and signaling that the analyst views the selloff as excessive.
• Neutral Sentiment: Alignment disputed the 3.5-Star rating for its California H3815 HMO contract, arguing that it conflicts with the plan’s clinical outcomes, quality measures and member-experience results. The company intends to pursue administrative remedies and possible litigation, although the outcome and timing are uncertain. Alignment Healthcare Stock and 2027 Star Ratings
• Negative Sentiment: The California H3815 HMO contract received only 3.5 Stars. Investors appear concerned that the lower rating could reduce the plan’s competitive appeal and affect future Medicare Advantage economics, helping drive the sharp decline in ALHC. Alignment Healthcare Medicare Plan Downgrade
• Negative Sentiment: William Blair downgraded Alignment Healthcare to “Market Perform,” adding to pressure on the stock. The company also faces a reduced valuation benchmark after KeyCorp’s target cut, even though KeyCorp retained its bullish rating. William Blair Downgrade
• Negative Sentiment: Recent insider selling—including a 32,479-share sale by Chief Medical Officer Hyong Kim—adds to investor caution, though the transaction was reported as being used to cover tax withholding on vested equity awards.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc is a technology-enabled Medicare Advantage company focused on providing health coverage and care services for older adults. The company offers Medicare Advantage plans that combine medical benefits with care coordination, wellness support, and other services designed to help members manage their health.

Alignment operates through an integrated healthcare model that uses its proprietary technology platform to support physicians, care teams, and members. Its services include personalized care management, clinical coordination, virtual and in-home support, and member assistance through its concierge-style approach.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.